Literature DB >> 9367411

Alteration of DNA methylation levels in MRL lupus mice.

M Mizugaki1, T Yamaguchi, S Ishiwata, H Shindo, T Hishinuma, S Nozaki, M Nose.   

Abstract

Recent reports suggest that DNA methylation is involved in the cause of autoimmune disease. We investigated the alteration of DNA methylation levels in lupus strains of mice, MRL/lpr as a model, which develop an age-dependent lymphadenopathy and autoimmune disease. DNA methylation levels of thymus and axillary lymph nodes in 20-week-old MRL/lpr mice, which are in an autoimmune disease state, were lower than those of 4-week-old MRL/lpr mice with no symptoms as yet. No significant changes were observed in MRL/+ strain mice, which seemed normal at least 20 weeks, while DNA methylation levels in the spleen of both strains of mice increased significantly from the age of 4 to 20 weeks. However, no significant changes of DNA methylation levels in peripheral blood were observed with ageing in MRL strains. Moreover, we clarified that administration of 5-azacytidine had a strong effect on longer survival of MRL/lpr mice and reduced DNA methylation levels in the axillary lymph nodes and spleen. The possible relevance of DNA methylation levels to the progression of autoimmune disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367411      PMCID: PMC2265501          DOI: 10.1111/j.1365-2249.1997.tb08326.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.

Authors:  A K Yi; D M Klinman; T L Martin; S Matson; A M Krieg
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

2.  Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.

Authors:  M Nose; M Nishimura; M Kyogoku
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

Review 4.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

Review 5.  5-Methylcytosine in eukaryotic DNA.

Authors:  M Ehrlich; R Y Wang
Journal:  Science       Date:  1981-06-19       Impact factor: 47.728

6.  Genomic 5-methyldeoxycytidine decreases with age.

Authors:  V L Wilson; R A Smith; S Ma; R G Cutler
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

7.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

8.  Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells.

Authors:  B Richardson
Journal:  Hum Immunol       Date:  1986-12       Impact factor: 2.850

9.  Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA.

Authors:  C W Gehrke; R A McCune; M A Gama-Sosa; M Ehrlich; K C Kuo
Journal:  J Chromatogr       Date:  1984-09-28

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Epigenomics of autoimmune diseases.

Authors:  Bhawna Gupta; R David Hawkins
Journal:  Immunol Cell Biol       Date:  2015-03       Impact factor: 5.126

2.  Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Eva Balada; Josep Ordi-Ros; Silvia Serrano-Acedo; Luis Martinez-Lostao; Maria Rosa-Leyva; Miquel Vilardell-Tarrés
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

3.  Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus.

Authors:  Eva Balada; Jesús Castro-Marrero; Lledó Felip; Josep Ordi-Ros; Miquel Vilardell-Tarrés
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

4.  A single whole-body low dose X-irradiation does not affect L1, B1 and IAP repeat element DNA methylation longitudinally.

Authors:  Michelle R Newman; Pamela J Sykes; Benjamin J Blyth; Eva Bezak; Mark D Lawrence; Katherine L Morel; Rebecca J Ormsby
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 5.  Epigenetics of human diseases and scope in future therapeutics.

Authors:  Monis B Shamsi; Abdul S Firoz; Syed N Imam; Naweed Alzaman; Muhammad A Samman
Journal:  J Taibah Univ Med Sci       Date:  2017-05-22

Review 6.  The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Authors:  Haijing Wu; Yongjian Chen; Huan Zhu; Ming Zhao; Qianjin Lu
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

7.  Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.

Authors:  Sija Landman; Chiel van der Horst; Piet E J van Erp; Irma Joosten; Rob de Vries; Hans J P M Koenen
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

8.  Human Endogenous Retroviruses (HERVs) and Autoimmune Rheumatic Disease: Is There a Link?

Authors:  Nicola Tugnet; Paul Rylance; Denise Roden; Malgorzata Trela; Paul Nelson
Journal:  Open Rheumatol J       Date:  2013-03-22

Review 9.  Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences.

Authors:  Maria Stratigopoulou; Tijmen P van Dam; Jeroen E J Guikema
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.